Role of Elastase-2 as an Angiotensin II-Forming Enzyme in Rat Carotid Artery
Authors:
- Disney O SivieriDSDisney O Sivieri
- Carlos F SantosCSCarlos F Santos
- Milene K MoysésMMMilene K Moysés
- Eduardo B OliveiraEOEduardo B Oliveira
- Maria Cristina O SalgadoMSMaria Cristina O Salgado
- 1 October 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 46 (4) , 498-504
Abstract
We have described the biochemical, enzymatic, and structural properties of a chymostatin-sensitive angiotensin (Ang) I-converting elastase-2 found in the rat mesenteric arterial bed perfusate. We determined the mRNA for elastase-2 and its relative role in generating Ang II in the rat isolated aorta and carotid artery rings. In carotid rings, the Ang I-induced vasoconstrictor effect was only partially inhibited by captopril or chymostatin, whereas that of tetradecapeptide renin substrate (TDP) was greatly inhibited by chymostatin but unaffected by captopril; however, Ang I- and TDP-induced effects were abolished by the combination of both inhibitors. Effects of [Pro11-D-Ala12]-Ang I (PDA), an Ang I-converting enzyme (ACE)-resistant biologically inactive precursor of Ang II were blocked by chymostatin or N-acetyl-Ala-Ala-Pro-Leu-chloromethylketone (elastase-2 inhibitor) in carotid artery. PDA failed to induce an effect in aortic rings, and Ang I-induced contractions were completely inhibited by captopril. The mRNA for rat elastase-2 was detected in aorta, carotid, and mesenteric arteries, although its expression was found to be less important in aorta. These findings indicate the presence of a functional alternative pathway to ACE for Ang II generation in rat carotid artery and represent strong evidence of a physiological role for elastase-2; however, its functional contribution to Ang II formation in aorta appears to be negligible.Keywords
This publication has 27 references indexed in Scilit:
- Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension researchJournal of Molecular Medicine, 2001
- Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular systemAmerican Journal of Physiology-Heart and Circulatory Physiology, 1998
- Pathways for Angiotensin II Generation in Intact Human TissueHypertension, 1998
- [Pro11,d-Ala12]angiotensin I has rapid onset vasoconstrictor activity in the catAmerican Journal of Physiology-Endocrinology and Metabolism, 1997
- Characterization of angiotensin II formation in human isolated bladder by selective inhibitors of ACE and human chymase: a functional and biochemical studyBritish Journal of Pharmacology, 1997
- Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human HeartCirculation Research, 1997
- Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon.Journal of Clinical Investigation, 1995
- Vasoconstrictor action of angiotensin I-convertase and the synthetic substrate (Pro11,D-Ala12)-angiotensin I.Hypertension, 1994
- Tissue Renin-Angiotensin SystemJournal of Cardiovascular Pharmacology, 1987
- Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cells.Proceedings of the National Academy of Sciences, 1987